Stereotactic Ablative Radiotherapy in the Management of Synchronous Early Stage Non-Small Cell Lung Cancers

被引：0
|
作者：
Ayoub, Z. [1 ]
Brooks, E. [1 ]
Welsh, J. [1 ]
Chen, A. [1 ]
Gandhi, S. [1 ]
Heymach, J. [1 ]
Vaporciyan, A. [1 ]
Chang, J. [1 ]
机构：
[1] UT MDACC, Houston, TX USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
Earlystage non-small cell lung cancer; Synchronous lesions; Stereotactic ablative radiation therapy;
D O I：
10.1016/j.jtho.2019.08.545
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MA06.10
引用
收藏
页码：S272 / S272
页数：1
相关论文
共 50 条
  • [31] The Role of Stereotactic Ablative Radiotherapy for Early-Stage and Oligometastatic Non-small Cell Lung Cancer: Evidence for Changing Paradigms
    Dahele, Max
    Senan, Suresh
    CANCER RESEARCH AND TREATMENT, 2011, 43 (02): : 75 - 82
  • [32] SYSTEMATIC REVIEW OF ECONOMIC EVALUATIONS ON STEREOTACTIC ABLATIVE RADIOTHERAPY FOR THE TREATMENT OF EARLY-STAGE NON-SMALL CELL LUNG CANCER
    Maia, De Albuquerque F.
    Rozman, L.
    Carvalho, De Andrade H.
    De Soarez, P. C.
    VALUE IN HEALTH, 2022, 25 (01) : S48 - S48
  • [33] Immune Activation in Early Stage Non-Small Cell Lung Cancer (NSCLC) following Stereotactic Ablative Radiotherapy (SABR) and Surgery
    Aerts, Joachim G.
    De Goeje, Pauline
    Schram, Merel
    Bezemer, Koen
    Kaijen-Lambers, Margaretha
    Hegmans, Joost
    De langen, Joop
    Maat, Alexander
    Nuyttens, Joost
    Hendriks, Rudi
    Smit, Egbert
    Senan, Suresh
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S326 - S326
  • [34] Stereotactic ablative radiotherapy for early stage non-small cell lung cancer: A critical literature review of predictive factors of relapse
    Loganadane, Gokoulakrichenane
    Martinetti, Florent
    Mercier, Olaf
    Krhili, Samar
    Riet, Francois-Georges
    Mbagui, Rodrigue
    To, Hanh
    Le Pechoux, Cecile
    Levy, Antonin
    CANCER TREATMENT REVIEWS, 2016, 50 : 240 - 246
  • [35] Stereotactic Ablative Radiotherapy with Nivolumab for Early-Stage Operable Non-Small Cell Lung Cancer: a phase 2 study
    Beal, J.
    Gomes, D.
    Taranto, P.
    Koch, L.
    Rezende, A. C.
    Samano, M.
    Bibas, B.
    Gomes, O.
    Campregher, P.
    Severino, P.
    Marti, L.
    Paes, V.
    Chate, R.
    Sales, D.
    Schvartsman, G.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S651 - S652
  • [36] Audit of radiotherapy plan quality for stereotactic ablative radiotherapy (SABR) for stage 1 non-small cell lung cancer
    Pascoe, A. C.
    Foweraker, K.
    Esler, C.
    Morgan, S.
    Wallace, A.
    Launders, D.
    Harron, E.
    CLINICAL ONCOLOGY, 2016, 28 : S4 - S4
  • [37] What is the role of stereotactic ablative radiotherapy in the management of surgically resectable and operable stage I non-small cell lung cancer?
    Love, Susannah M.
    Hardman, Gillian
    Mashar, Ruchir
    Shah, Rajesh D.
    JOURNAL OF THORACIC DISEASE, 2017, 9 (05) : E483 - E486
  • [38] Stereotactic ablative radiotherapy for non-small cell lung cancer: early experience in Aberdeen Royal Infirmary
    Laws, K.
    Duncan, A.
    Tan, W. W.
    Stilwell, C.
    Moleron, R.
    LUNG CANCER, 2019, 127 : S74 - S74
  • [39] Stereotactic Ablative Radiotherapy for Early Stage Non-Small Lung Cancer and Pulmonary Oligometastases in a New Zealand Population
    Yasin, N. A. B. Haji Mohd
    Geary, R.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S270 - S270
  • [40] STEREOTACTIC BODY ABLATIVE RADIOTHERAPY FOR STAGE I NON SMALL CELL LUNG CANCER
    Beltramo, G.
    Bergantin, A.
    Martinotti, A.
    Bonfanti, P.
    Bianchi, L. C.
    RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S570 - S571
12345